Quest Diagnostics Incorporated
DGX
$168.48
$0.62630.37%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.52B | 10.16B | 9.87B | 9.54B | 9.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.52B | 10.16B | 9.87B | 9.54B | 9.35B |
| Cost of Revenue | 7.03B | 6.80B | 6.60B | 6.39B | 6.26B |
| Gross Profit | 3.49B | 3.36B | 3.27B | 3.15B | 3.09B |
| SG&A Expenses | 1.84B | 1.77B | 1.74B | 1.69B | 1.63B |
| Depreciation & Amortization | 147.00M | 137.00M | 127.00M | 117.00M | 112.00M |
| Other Operating Expenses | 2.00M | 1.00M | 1.00M | -2.00M | 0.00 |
| Total Operating Expenses | 9.02B | 8.70B | 8.47B | 8.19B | 8.00B |
| Operating Income | 1.51B | 1.46B | 1.41B | 1.35B | 1.35B |
| Income Before Tax | 1.29B | 1.21B | 1.19B | 1.14B | 1.14B |
| Income Tax Expenses | 289.00M | 266.00M | 273.00M | 245.00M | 248.00M |
| Earnings from Continuing Operations | 1.00K | 948.00 | 921.00 | 890.00 | 890.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -54.00M | -51.00M | -50.00M | -49.00M | -50.00M |
| Net Income | 950.00M | 897.00M | 871.00M | 841.00M | 840.00M |
| EBIT | 1.51B | 1.46B | 1.41B | 1.35B | 1.35B |
| EBITDA | 2.05B | 1.97B | 1.90B | 1.81B | 1.80B |
| EPS Basic | 8.47 | 8.02 | 7.78 | 7.52 | 7.50 |
| Normalized Basic EPS | 6.96 | 6.74 | 6.62 | 6.42 | 6.46 |
| EPS Diluted | 8.38 | 7.94 | 7.72 | 7.39 | 7.36 |
| Normalized Diluted EPS | 6.87 | 6.65 | 6.55 | 6.36 | 6.39 |
| Average Basic Shares Outstanding | 446.00M | 445.00M | 445.00M | 446.00M | 446.00M |
| Average Diluted Shares Outstanding | 452.00M | 451.00M | 450.00M | 450.00M | 451.00M |
| Dividend Per Share | 3.10 | 3.05 | 3.00 | 2.96 | 2.92 |
| Payout Ratio | 36.00% | 37.46% | 38.00% | 38.88% | 38.45% |